Yet, in opposition to their study, we did not observe any effect of IL-1β treatment on sHLA-E production by tumor cells, probably due to a low expression of IL-1 receptor (IL-1R1) by the tumor cell lines tested in our study. Here, IL1B is linked to neoplasm.